We use cookies for a better user experience. Read our Privacy Policy

I Agree

Fibrin Sealants Market

Fibrin Sealants Market (Dosage Form: Liquid, Patch, and Powder; Indication: General Surgery, Cardiovascular Surgery, Wound Management, Orthopedic Surgery, and Others; and End User: Hospitals, Ambulatory Surgical Centers, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

Need of Improved Efficiency in Several Types of Surgeries Influencing Fibrin Sealants Market Growth

The growing need across the world to efficiently manage hemostasis and tissue sealing while performing surgery has had a great influence on the evolution of modern surgical procedures. A group of agents identified as surgical tissue adhesives has been extended to promote hemostasis and tissue sealing throughout surgery, and these comprise both natural and synthetic agents. Fibrin sealants are the most efficient tissue adhesives currently available in the market. They are biocompatible and biodegradable. The fibrin sealants are composed of refined, virus-inactivated human fibrinogen, human thrombin, and sometimes added elements, such as virus-inactivated human factor XIII and bovine aprotinin. These agents imitate the final steps of the physiological clotting cascade to create a fibrin clot. The increasing use of fibrin sealants in the healthcare industry is anticipated to fuel the global fibrin sealants market during the forecast period.

fibrin sealants market infographic

Request a sample to get extensive insights into the Fibrin Sealants Market

Decreased Surgical Procedures Due to COVID-19 Hindered Global Demand for Fibrin Sealants

The global COVID-19 pandemic has had a significant impact on almost every industry, including the fibrin sealants market. Most of the healthcare industry shifted its focus on fighting the coronavirus outbreak, while various surgeries and diagnostic treatments were postponed, canceled, or performed in a limited amount. Surgeries performed with fibrin sealants, hemostats, or adhesion barriers have declined significantly across the world, thus hampering the growth rate of the fibrin sealants market. Businesses witnessed reduced demand for sealants with a decreasing number of surgeries. Many patients avoided operating in contagious environments fearing severe consequences. The healthcare industry suffered due to limited resources and restrictions on the global trade. Thus, it affected the growth of the fibrin sealants market.

Major market players are currently focusing on developments and innovations in the ways to conduct practices using DTC and remote operations. With the growing number of coronary artery disease across the world, the fibrin sealants market is expected to witness demand post-COVID-19. The number of these cases is anticipated to rise with the growing population and insufficient healthcare in underdeveloped countries. As the pandemic is nearing its end, companies are preparing to expand their business activities and productivity to flatten the demand curve. This might prove propitious for the global fibrin sealants market during the projected period.

To understand how our report can bring difference to your business strategy, Ask for a brochure

Rising Prevalence of Blood Related Disorders Drive Demand for Fibrin Sealants

Fibrin sealants are presently used in several surgical practices, including cardiovascular surgery, thoracic surgery, neurosurgery, plastic & reconstructive surgery, and dental surgery. The use of fibrin sealants has a resolute effect on surgical outcomes, such as improved time to hemostasis, decreased blood loss, and reduced complexities. The report describes the evolution of fibrin sealants, the composition of currently available products, and their use in surgical practice. Many electrosurgical instruments are available, and used for analysis and sealing vascular structures. The topical hemostatic agents, such as fibrin sealants, are used to control bleeding from surfaces or cavities that are not responsive to suturing, electrosurgery, or other functional instruments including the argon plasma coagulator. An increment in the number of surgical procedures and patients with blood-related disorders such as hemophilia is anticipated to boost the global fibrin sealants market in the upcoming future.

North America Most Likely to Dominate Fibrin Sealants Market

There is a surge in awareness about medical treatments. Combined with the rising literacy rate, there has been an increase in the adoption of new efficient surgical products, which is likely to fuel the demand in the global market. Moreover, the involvement of governments and organizations to promote information regarding chronic diseases and treatments will raise the number of patients in the upcoming future. Owing to the increasing aging population in North America, the region is expected to a hold major share of the global fibrin sealants market. The global fibrin sealants market is expected to expand at a CAGR of 6.7% from 2021 to 2031.

fibrin sealants market segmentation

Stuck in a neck-to-neck competition with other brands? Request a custom report on Fibrin Sealants Market

Analysts’ Viewpoint

The global fibrin sealant market is principally driven by the increasing predominance of important surgeries and traumatic injuries. Recent improvements in technology and products have resulted in the development of biocompatible sealants, which reduce complexities and support the normal movement of tissues without any restraint on the functioning of the organs. Furthermore, North America accounted for the highest revenue share of the fibrin sealants market in 2019 and is expected to lead the regional segment during the forecast period. Advancements in hemostasis technology and rising number of chronic diseases are likely to aid in the future growth of the fibrin sealants market.

Fibrin Sealants Market: Overview

  • This report analyzes the current and future prospects of the global fibrin sealants market. Increase in patient pool with different chronic diseases, rise in number of trauma cases, and surge in geriatric population are the key factors projected to fuel the growth of the global fibrin sealants market during the forecast period.
  • The report provides an elaborate executive summary, which comprises a snapshot of the various segments of the global fibrin sealants market. The report also provides information and data analysis of the global fibrin sealants market about segments based on dosage form, indication, end user, and region.
  • The overview section of the report provides detailed qualitative analysis of drivers and restraints affecting the global fibrin sealants market along with opportunities in the global market
  • The global fibrin sealants market report includes company profiles and competitive matrix, which provide data about their businesses, product portfolios, and competitive landscape in the global fibrin sealants market
  • The report includes data analysis on the global fibrin sealants market attractiveness by region and segments
  • The last section of the report provides quantitative and qualitative analysis on market share of key players operating in the global fibrin sealants market. It elaborates on the key competitive strategies adopted by the major industry players, thereby presenting a thorough understanding of the competitive scenario in the global fibrin sealants market.

Fibrin Sealants Market: Key Segments

  • In terms of dosage form, the global fibrin sealants market has been classified into liquid, patch, and powder. The liquid segment held major share of the global fibrin sealants market in 2020.
  • Based on indication, the global fibrin sealants market has been categorized into general surgery cardiovascular surgery, wound management, orthopedic surgery, and others
  • In terms of end user, the global fibrin sealants market has been divided into hospitals, ambulatory surgical centers, and others. The hospitals segment is anticipated to lead the global fibrin sealants market during the forecast period.
  • The market size and forecast for each of these segments have been provided from 2017 to 2031. The CAGR of respective segment has also been provided for the forecast period from 2021 to 2031, considering 2020 as the base year.

Fibrin Sealants Market: Regional Outlook

  • In terms of region, the global fibrin sealants market has been segmented into North America (U.S. and Canada), Europe (U.K., Germany, Spain, Italy, France, and Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (GCC Countries, South Africa, and Rest of Middle East & Africa)
  • The report provides market size and forecast for each region and country/sub-region from 2017 to 2031. Compound annual growth rate (CAGR) of each of these regions and countries have also been provided for the forecast period from 2021 to 2031, considering 2020 as the base year. The fibrin sealants market study also covers the competitive scenario in these regions.

Companies Mentioned in Report

  • Key players in the global fibrin sealants market have been profiled based on key aspects such as company overview, product portfolio, financial overview, recent developments, and competitive business strategies
  • Major companies profiled in the global fibrin sealants market report are
    • Baxter
    • Pfizer, Inc.
    • Takeda Pharmaceutical Company
    • Johnson & Johnson (Ethicon, Inc.)
    • Grifols, S.A.
    • CSL Limited
    • Vivostat A/S
    • Stryker
    • Hemarus
    • Asahi Kasei Corporation

Fibrin Sealants Market – Segmentation

Dosage Form
  • Liquid
  • Patch
  • Powder
Indication
  • General Surgery
  • Cardiovascular Surgery
  • Wound Management
  • Orthopedic Surgery
  • Others
End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Others
Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Interested in this report?
Get a FREE sample now!

Get Free Sample

*Get Sample Report (PDF) sent to your email within minutes

Frequently Asked Questions

What is the total market worth of fibrin sealants market?

The global fibrin sealants market was worth US$ 900 Mn and is projected to reach a value of US$ 2 Bn by the end of 2031

What is the anticipated CAGR of the fibrin sealants market in the forecast period?

Fibrin sealants market is anticipated to grow at a CAGR of 6.7% during the forecast period

Which region is expected to project the highest market share in fibrin sealants market?

North America accounted for a major share of the global fibrin sealants market

What are the key driving factors for the growth of fibrin sealants market?

Fibrin sealants market is driven by increase in number of patients with chronic diseases, rise in trauma cases, and surge in geriatric population are anticipated to drive the global market from 2021 to 2031

Who are the key players in the global fibrin sealants market?

Key players in the global fibrin sealants market include Baxter, Pfizer, Inc., Takeda Pharmaceutical Company, Johnson & Johnson (Ethicon, Inc.), Grifols, S.A., CSL Limited, Vivostat A/S, Stryker, Hemarus, and Asahi Kasei Corporation

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Fibrin Sealants Market

4. Market Overview

    4.1. Introduction

        4.1.1. Market Introduction

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Fibrin Sealants Market Analysis and Forecast, 2017–2031

        4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

    5.1. Technological Advancements

    5.2. Key Industry Events (mergers, acquisitions, collaborations, partnerships, etc.)

    5.3. TISSEEL Fibrin Sealant Sales and Forecast (US$ Mn) 2017-2031, by Country/Region

    5.4. % Share of Marketed Fibrin Sealants by Product/Company in the Global Fibrin Sealants Market (2020)

    5.5. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)

6. Global Fibrin Sealants Market Analysis and Forecast, by Dosage Form

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Market Value Forecast, by Dosage Form, 2017–2031

        6.3.1. Liquid

        6.3.2. Patch

        6.3.3. Powder

    6.4. Market Attractiveness Analysis, by Dosage Form

7. Global Fibrin Sealants Market Analysis and Forecast, by Indication

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Market Value Forecast, by Indication, 2017–2031

        7.3.1. General Surgery

        7.3.2. Cardiovascular Surgery

        7.3.3. Wound Management

        7.3.4. Orthopedic Surgery

        7.3.5. Others

    7.4. Market Attractiveness Analysis, by Indication

8. Global Fibrin Sealants Market Analysis and Forecast, by End-user

    8.1. Introduction & Definition

    8.2. Key Findings / Developments

    8.3. Market Value Forecast, by End-user, 2017–2031

        8.3.1. Hospitals

        8.3.2. Ambulatory Surgical Centers

        8.3.3. Others

    8.4. Market Attractiveness Analysis, by End-user

9. Global Fibrin Sealants Market Analysis and Forecast, by Region

    9.1. Key Findings

    9.2. Market Value Forecast by Region

        9.2.1. North America

        9.2.2. Europe

        9.2.3. Asia Pacific

        9.2.4. Latin America

        9.2.5. Middle East & Africa

    9.3. Market Attractiveness Analysis, by Country/Region

10. North America Fibrin Sealants Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. Market Value Forecast, by Dosage Form, 2017–2031

        10.2.1. Liquid

        10.2.2. Patch

        10.2.3. Powder

    10.3. Market Value Forecast, by Indication, 2017–2031

        10.3.1. General Surgery

        10.3.2. Cardiovascular Surgery

        10.3.3. Wound Management

        10.3.4. Orthopedic Surgery

        10.3.5. Others

    10.4. Market Value Forecast, by End-user, 2017–2031

        10.4.1. Hospitals

        10.4.2. Ambulatory Surgical Centers

        10.4.3. Others

    10.5. Market Value Forecast, by Country, 2017–2031

        10.5.1. U.S.

        10.5.2. Canada

    10.6. Market Attractiveness Analysis

        10.6.1. By Dosage Form

        10.6.2. By Indication

        10.6.3. By End-user

        10.6.4. By Country

11. Europe Fibrin Sealants Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Market Value Forecast, by Dosage Form, 2017–2031

        11.2.1. Liquid

        11.2.2. Patch

        11.2.3. Powder

    11.3. Market Value Forecast, by Indication, 2017–2031

        11.3.1. General Surgery

        11.3.2. Cardiovascular Surgery

        11.3.3. Wound Management

        11.3.4. Orthopedic Surgery

        11.3.5. Others

    11.4. Market Value Forecast, by End-user, 2017–2031

        11.4.1. Hospitals

        11.4.2. Ambulatory Surgical Centers

        11.4.3. Others

    11.5. Market Value Forecast, by Country/Sub-region, 2017–2031

        11.5.1. Germany

        11.5.2. U.K.

        11.5.3. France

        11.5.4. Spain

        11.5.5. Italy

        11.5.6. Rest of Europe

    11.6. Market Attractiveness Analysis

        11.6.1. By Dosage Form

        11.6.2. By Indication

        11.6.3. By End-user

        11.6.4. By Country/Sub-region

12. Asia Pacific Fibrin Sealants Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Market Value Forecast, by Dosage Form, 2017–2031

        12.2.1. Liquid

        12.2.2. Patch

        12.2.3. Powder

    12.3. Market Value Forecast, by Indication, 2017–2031

        12.3.1. General Surgery

        12.3.2. Cardiovascular Surgery

        12.3.3. Wound Management

        12.3.4. Orthopedic Surgery

        12.3.5. Others

    12.4. Market Value Forecast, by End-user, 2017–2031

        12.4.1. Hospitals

        12.4.2. Ambulatory Surgical Centers

        12.4.3. Others

    12.5. Market Value Forecast, by Country/Sub-region, 2017–2031

        12.5.1. China

        12.5.2. Japan

        12.5.3. India

        12.5.4. Australia & New Zealand

        12.5.5. Rest of Asia Pacific

    12.6. Market Attractiveness Analysis

        12.6.1. By Dosage Form

        12.6.2. By Indication

        12.6.3. By End-user

        12.6.4. By Country/Sub-region

13. Latin America Fibrin Sealants Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Market Value Forecast, by Dosage Form, 2017–2031

        13.2.1. Liquid

        13.2.2. Patch

        13.2.3. Powder

    13.3. Market Value Forecast, by Indication, 2017–2031

        13.3.1. General Surgery

        13.3.2. Cardiovascular Surgery

        13.3.3. Wound Management

        13.3.4. Orthopedic Surgery

        13.3.5. Others

    13.4. Market Value Forecast, by End-user, 2017–2031

        13.4.1. Hospitals

        13.4.2. Ambulatory Surgical Centers

        13.4.3. Others

    13.5. Market Value Forecast, by Country/Sub-region, 2018–2030

        13.5.1. Brazil

        13.5.2. Mexico

        13.5.3. Rest of Latin America

    13.6. Market Attractiveness Analysis

        13.6.1. By Dosage Form

        13.6.2. By Indication

        13.6.3. By End-user

        13.6.4. By Country/Sub-region

14. Middle East & Africa Fibrin Sealants Market Analysis and Forecast

    14.1. Introduction

        14.1.1. Key Findings

    14.2. Market Value Forecast, by Dosage Form, 2017–2031

        14.2.1. Liquid

        14.2.2. Patch

        14.2.3. Powder

    14.3. Market Value Forecast, by Indication, 2017–2031

        14.3.1. General Surgery

        14.3.2. Cardiovascular Surgery

        14.3.3. Wound Management

        14.3.4. Orthopedic Surgery

        14.3.5. Others

    14.4. Market Value Forecast, by End-user, 2017–2031

        14.4.1. Hospitals

        14.4.2. Ambulatory Surgical Centers

        14.4.3. Others

    14.5. Market Value Forecast, by Country/Sub-region, 2018–2030

        14.5.1. GCC Countries

        14.5.2. South Africa

        14.5.3. Rest of Middle East & Africa

    14.6. Market Attractiveness Analysis

        14.6.1. By Dosage Form

        14.6.2. By Indication

        14.6.3. By End-user

        14.6.4. By Country/Sub-region

15. Competition Landscape

    15.1. Market Player - Competition Matrix (by tier and size of companies)

    15.2. Market Share Analysis/Ranking, by Company, 2020

    15.3. Company Profiles

        15.3.1. Baxter

            15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.1.2. Growth Strategies

            15.3.1.3. SWOT Analysis

        15.3.2. Pfizer Inc.

            15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.2.2. Growth Strategies

            15.3.2.3. SWOT Analysis

        15.3.3. Takeda Pharmaceutical Company

            15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.3.2. Growth Strategies

            15.3.3.3. SWOT Analysis

        15.3.4. Johnson & Johnson (Ethicon, Inc.)

            15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.4.2. Growth Strategies

            15.3.4.3. SWOT Analysis

        15.3.5. Grifols, S.A.

            15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.5.2. Growth Strategies

            15.3.5.3. SWOT Analysis

        15.3.6. CSL Limited

            15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.6.2. Growth Strategies

            15.3.6.3. SWOT Analysis

        15.3.7. Vivostat A/S

            15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.7.2. Growth Strategies

            15.3.7.3. SWOT Analysis

        15.3.8. Stryker

            15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.8.2. Growth Strategies

            15.3.8.3. SWOT Analysis

        15.3.9. Hemarus

            15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.9.2. Growth Strategies

            15.3.9.3. SWOT Analysis

        15.3.10. Asahi Kasei Corporation

            15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.10.2. Growth Strategies

            15.3.10.3. SWOT Analysis

List of Tables

Table 01: Key Industry Events

Table 02: ISSEEL Fibrin Sealant Sales and Forecast (US$ Mn) 2017-2031, by Region

Table 03: Global Fibrin Sealant Market Value (US$ Mn) Forecast, by Dosage Form, 2017–2031

Table 04: Global Fibrin Sealant Market Value (US$ Mn) Forecast, by Indication, 2017–2031

Table 05: Global Fibrin Sealant Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 06: Global Fibrin Sealant Market Value (US$ Mn) Forecast, by Region, 2017–2031

Table 07: North America Fibrin Sealants Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 08: North America Fibrin Sealants Market Value (US$ Mn) Forecast, by Dosage Form, 2017–2031

Table 09: North America Fibrin Sealants Market Value (US$ Mn) Forecast, by Indication, 2017–2031

Table 10: North America Fibrin Sealants Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 11: Europe Fibrin Sealants Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 12: Europe Fibrin Sealants Market Value (US$ Mn) Forecast, by Dosage Form, 2017–2031

Table 13: Europe Fibrin Sealants Market Value (US$ Mn) Forecast, by Indication, 2017–2031

Table 14: Europe Fibrin Sealants Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 15: Asia Pacific Fibrin Sealants Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 16: Asia Pacific Fibrin Sealants Market Value (US$ Mn) Forecast, by Dosage Form, 2017–2031

Table 17: Asia Pacific Fibrin Sealants Market Value (US$ Mn) Forecast, by Indication, 2017–2031

Table 18: Asia Pacific Fibrin Sealants Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 19: Latin America Fibrin Sealants Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031

Table 20: Latin America Fibrin Sealants Market Value (US$ Mn) Forecast, by Dosage Form, 2017–2031

Table 21: Latin America Fibrin Sealants Market Value (US$ Mn) Forecast, by Indication, 2017–2031

Table 22: Latin America Fibrin Sealants Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 23: Middle East & Africa Fibrin Sealants Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 24: Middle East & Africa Fibrin Sealants Market Value (US$ Mn) Forecast, by Dosage Form, 2017–2031

Table 25: Middle East & Africa Fibrin Sealants Market Value (US$ Mn) Forecast, by Indication, 2017–2031

Table 26: Middle East & Africa Fibrin Sealants Market Value (US$ Mn) Forecast, by End-user, 2017–2031

List of Figures

Figure 01: Global Fibrin Sealant Market Value (US$ Mn) Forecast, 2017–2031

Figure 02: Global Fibrin Sealant Market Value Share, by Dosage Form, 2020

Figure 03: Global Fibrin Sealant Market Value Share, by Indication, 2020

Figure 04: Global Fibrin Sealant Market Value Share, by End-user, 2020

Figure 05: Global Fibrin Sealant Market Value Share, by Region, 2020

Figure 06: Global Fibrin Sealant Market Value Share Analysis, by Dosage Form, 2020 and 2031

Figure 07: Global Fibrin Sealant Market Attractiveness Analysis, by Dosage Form, 2021–2031

Figure 08: Global Fibrin Sealant Market Value (US$ Mn), by Liquid, 2017–2031

Figure 09: Global Fibrin Sealant Market Value (US$ Mn), by Patch, 2017–2031

Figure 10: Global Fibrin Sealant Market Value (US$ Mn), by Powder, 2017–2031

Figure 11: Global Fibrin Sealant Market Value Share Analysis, by Indication, 2020 and 2031

Figure 12: Global Fibrin Sealant Market Attractiveness Analysis, by Indication, 2021–2031

Figure 13: Global Fibrin Sealant Market Value (US$ Mn), by General Surgery, 2017–2031

Figure 14: Global Fibrin Sealant Market Value (US$ Mn), by Cardiovascular Surgery, 2017–2031

Figure 15: Global Fibrin Sealant Market Value (US$ Mn), by Wound Management, 2017–2031

Figure 16: Global Fibrin Sealant Market Value (US$ Mn), by Orthopedic Surgery, 2017–2031

Figure 17: Global Fibrin Sealant Market Value (US$ Mn), by Others, 2017–2031

Figure 18: Global Fibrin Sealant Market Value Share Analysis, by End-user, 2020 and 2031

Figure 19: Global Fibrin Sealant Market Attractiveness Analysis, by End-user, 2021–2031

Figure 20: Global Fibrin Sealant Market Value (US$ Mn), by Hospitals, 2017–2031

Figure 21: Global Fibrin Sealant Market Value (US$ Mn), by Ambulatory Surgical Centers, 2017–2031

Figure 22: Global Fibrin Sealant Market Value (US$ Mn), by Others, 2017–2031

Figure 23: Global Fibrin Sealant Market Value Share Analysis, by Region, 2020 and 2031

Figure 24: Global Fibrin Sealant Market Attractiveness Analysis, by Region, 2021–2031

Figure 25: North America Fibrin Sealants Market Value (US$ Mn) Forecast, 2017–2031

Figure 26: North America Fibrin Sealants Market Value Share Analysis, by Country/Sub-region, 2020 and 2031

Figure 27: North America Fibrin Sealants Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 28: North America Fibrin Sealants Market Value Share Analysis, by Dosage Form, 2020 and 2031

Figure 29: North America Fibrin Sealants Market Attractiveness Analysis, by Dosage Form, 2021–2031

Figure 30: North America Fibrin Sealants Market Value Share Analysis, by Indication, 2020 and 2031

Figure 31: North America Fibrin Sealants Market Attractiveness Analysis, by Indication, 2021–2031

Figure 32: North America Fibrin Sealants Market Value Share Analysis, by End-user, 2020 and 2031

Figure 33: North America Fibrin Sealants Market Attractiveness Analysis, by End-user, 2021–2031

Figure 34: Europe Fibrin Sealants Market Value (US$ Mn) Forecast, 2017–2031

Figure 35: Europe Fibrin Sealants Market Value Share Analysis, by Country/Sub-region, 2020 and 2031

Figure 36: Europe Fibrin Sealants Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 37: Europe Fibrin Sealants Market Value Share Analysis, by Dosage Form, 2020 and 2031

Figure 38: Europe Fibrin Sealants Market Attractiveness Analysis, by Dosage Form, 2021–2031

Figure 39: Europe Fibrin Sealants Market Value Share Analysis, by Indication, 2020 and 2031

Figure 40: Europe Fibrin Sealants Market Attractiveness Analysis, by Indication, 2021–2031

Figure 41: Europe Fibrin Sealants Market Value Share Analysis, by End-user, 2020 and 2031

Figure 42: Europe Fibrin Sealants Market Attractiveness Analysis, by End-user, 2021–2031

Figure 43: Asia Pacific Fibrin Sealants Market Value (US$ Mn) Forecast, 2017–2031

Figure 44: Asia Pacific Fibrin Sealants Market Value Share Analysis, by Country/Sub-region, 2020 and 2031

Figure 45: Asia Pacific Fibrin Sealants Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 46: Asia Pacific Fibrin Sealants Market Value Share Analysis, by Dosage Form, 2020 and 2031

Figure 47: Asia Pacific Fibrin Sealants Market Attractiveness Analysis, by Dosage Form, 2021–2031

Figure 48: Asia Pacific Fibrin Sealants Market Value Share Analysis, by Indication, 2020 and 2031

Figure 49: Asia Pacific Fibrin Sealants Market Attractiveness Analysis, by Indication, 2021–2031

Figure 50: Asia Pacific Fibrin Sealants Market Value Share Analysis, by End-user, 2020 and 2031

Figure 51: Asia Pacific Fibrin Sealants Market Attractiveness Analysis, by End-user, 2021–2031

Figure 52: Latin America Fibrin Sealants Market Value (US$ Mn) Forecast, 2017–2031

Figure 53: Latin America Fibrin Sealants Market Value Share Analysis, by Country/Sub-region, 2020 and 2031

Figure 54: Latin America Fibrin Sealants Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 55: Latin America Fibrin Sealants Market Value Share Analysis, by Dosage Form, 2020 and 2031

Figure 56: Latin America Fibrin Sealants Market Attractiveness Analysis, by Dosage Form, 2021–2031

Figure 57: Latin America Fibrin Sealants Market Value Share Analysis, by Indication, 2020 and 2031

Figure 58: Latin America Fibrin Sealants Market Attractiveness Analysis, by Indication, 2021–2031

Figure 59: Latin America Fibrin Sealants Market Value Share Analysis, by End-user, 2020 and 2031

Figure 60: Latin America Fibrin Sealants Market Attractiveness Analysis, by End-user, 2021–2031

Figure 61: Middle East & Africa Fibrin Sealants Market Value (US$ Mn) Forecast, 2017–2031

Figure 62: Middle East & Africa Fibrin Sealants Market Value Share Analysis, by Country/Sub-region, 2020 and 2031

Figure 63: Middle East & Africa Fibrin Sealants Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 64: Middle East & Africa Fibrin Sealants Market Value Share Analysis, by Dosage Form, 2020 and 2031

Figure 65: Middle East & Africa Fibrin Sealants Market Attractiveness Analysis, by Dosage Form, 2021–2031

Figure 66: Middle East & Africa Fibrin Sealants Market Value Share Analysis, by Indication, 2020 and 2031

Figure 67: Middle East & Africa Fibrin Sealants Market Attractiveness Analysis, by Indication, 2021–2031

Figure 68: Middle East & Africa Fibrin Sealants Market Value Share Analysis, by End-user, 2020 and 2031

Figure 69: Middle East & Africa Fibrin Sealants Market Attractiveness Analysis, by End-user, 2021–2031

Figure 70: Baxter Revenue (US$ Mn) and Y-o-Y Growth (%), 2017 – 2020

Figure 71: Baxter Breakdown of Net Sales (%), by Region/Country, 2020

Figure 72: Baxter Breakdown of Net Sales (%), by Business Units, 2020

Figure 73: Baxter R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2017–2020

Figure 74: Pfizer, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2020

Figure 75: Pfizer, Inc. Breakdown of Net Sales (%) Region/Country, 2020

Figure 76: Pfizer, Inc. Breakdown of Net Sales (%), by Biopharma Segment, 2020

Figure 77: Pfizer, Inc. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2017–2020

Figure 78: Takeda Pharmaceutical Company Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2020

Figure 79: Takeda Pharmaceutical Company Breakdown of Net Sales (%), by Region/Country, 2020

Figure 80: Takeda Pharmaceutical Company Breakdown of Net Sales (%), by Business Segment, 2020

Figure 81: Takeda Pharmaceutical Company R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2018–2020

Figure 82: Johnson & Johnson Revenue (US$ Mn) and Y-o-Y Growth (%), 2018–2020

Figure 83: Johnson & Johnson Breakdown of Net Sales (%) Region/Country, 2020

Figure 84: Johnson & Johnson Breakdown of Net Sales (%), by Business Segment, 2020

Figure 85: Johnson & Johnson R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2018–2020

Figure 86: Grifols, S.A. Revenue (US$ Mn) and Y-o-Y Growth (%), 2018–2020

Figure 87: Grifols, S.A. Breakdown of Net Sales (%) Region/Country, 2020

Figure 88: Grifols, S.A. Breakdown of Net Sales (%), by Business Segment, 2020

Figure 89: Grifols, S.A. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2018–2020

Figure 90: CSL Limited Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2020

Figure 91: CSL Limited Breakdown of Net Sales (%), by Region/Country, 2020

Figure 92: CSL Limited Revenue Breakdown of Net Sales (%), by Business Segment, 2020

Figure 93: CSL Limited R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2018–2020

Figure 94: Stryker Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2020

Figure 95: Stryker Breakdown of Net Sales (%), by Region/Country, 2020

Figure 96: Stryker Revenue Breakdown of Net Sales (%), by Business Segment, 2020

Figure 97: Asahi Kasei Corporation R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016–2019

Figure 98: Asahi Kasei Corporation Revenue Breakdown of Net Sales (%), by Business Segment, 2019

Figure 99: Asahi Kasei Corporation Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2019

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

367

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved